Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus

Pediatric Diabetes

Volumn 17, Issue 1, 2016, Pages 28-35

  Cherñavvsky, Daniel R ^a   Deboer, Mark D ^a   Keith Hynes, Patrick ^a   Mize, Benton ^a   Mcelwee, Molly ^a   Demartini, Susan ^a   Dunsmore, Spencer F ^a   Wakeman, Christian ^a   Kovatchev, Boris P ^a   Breton, Marc D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adolescent; Artificial pancreas; Closed loop control; Snacking; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE METER; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; MOBILE APPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMARTPHONE; BLOOD; DIABETES MELLITUS, TYPE 1; FAST FOOD; MEAL; METABOLISM; POSTPRANDIAL STATE; TREATMENT OUTCOME; UTILIZATION;

ADOLESCENT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MEALS; PANCREAS, ARTIFICIAL; POSTPRANDIAL PERIOD; SNACKS; TREATMENT OUTCOME;

EID: 84953281409     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12230     Document Type: Article

References (34)

1. Beck RW, Tamborlane WV, Bergenstal RM et al. The T1D exchange clinic registry. J Clin Endocrinol Metabol 2012: 97: 4383-4389.
2. Gerstl EM, Rabl W, Rosenbauer J et al. Metabolic control as reflectet by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27, 035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 2008: 167: 447-453.
3. Campbell M, Schatz D, Chen V et al. A contrast between children and adolescents with excellent and poor control: the T1D exchange clinic registry experience. Pediatr Diabetes 2014: 15: 110-117.
4. Guilfoyle SM, Crimmins NA, Hood KK. Blood glucose monitoring and glycemic control in adolescents with type 1 diabetes: meter downloads versus self-report. Pediatr Diabetes 2011: 12: 560-566.
5. Hilliard ME, Wu YP, Rausch J, Dolan LM, Hood KK. Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. J Adolescent Health 2013: 52: 28-34.
6. Smart CE, Ross K, Edge JA, King BR, McElduff P, Collins CE. Can children with type 1 diabetes and their caregivers estimate the carbohydrate content of meals and snacks? Diabet Med 2010: 27: 348-353.
7. Olinder AL, Kernell A, Smide B. Missed bolus doses: devastating for metabolic control in CSII-treated adolescents with type 1 diabetes. Pediatr Diabetes 2009: 10: 142-148.
8. VanderWel BW, Messer LH, Horton LA et al. Missed insulin boluses for snacks in youth with type 1 diabetes. Diabetes Care 2010: 33: 507-508.
9. Burdick J, Chase HP, Slover RH et al. Missed insulin meal boluses and elevated hemoglobin A(1c) levels in children receiving insulin pump therapy. Pediatrics 2004: 113: E221-E224.
10. O'Connell MA, Donath S, Cameron FJ. Poor adherence to integral daily tasks limits the efficacy of CSII in youth. Pediatr Diabetes 2011: 12: 556-559.
11. Patton SR, Clements MA, Fridlington A, Cohoon C, Turpin AL, DeLurgio SA. Frequency of mealtime insulin bolus as a proxy measure of adherence for children and youths with type 1 diabetes mellitus. Diabetes Technol Ther 2013: 15: 124-128.
12. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA 1996: 276: 1409-1415.
13. Cobelli C, Renard E, Kovatchev B. Artificial pancreas past, present, future. Diabetes 2011: 60: 2672-2682.
14. Weinzimer SA. Closed-loop artificial pancreas: current studies and promise for the future. Curr Opin Endocrinol Diabetes Obes 2012: 19: 88-92.
15. Bergenstal RM, Klonoff DC, Garg SK et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. New Engl J Med 2013: 369: 224-232.
16. Sherr JL, Cengiz E, Palerm CC et al. Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care 2013: 36: 2909-2914.
17. Elleri D, Allen JM, Kumareswaran K et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes. Diabetes Care 2013: 36: 838-844.
18. Phillip M, Battelino T, Atlas E et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. New Engl J Med 2013: 368: 824-833.
19. Breton M, Farret A, Bruttomesso D et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012: 61: 2230-2237.
20. Elleri D, Maltoni G, Allen JM et al. Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: randomised clinical trial. Diabetes Obes Metab 2014: 16: 1174-1178.
21. Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Cinar A. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. Diabetes Technol Ther 2013: 15: 386-400.
22. Keith-Hynes P, Guerlain S, Mize B et al. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. J Diabetes Sci Technol 2013: 7: 1416-1426.
23. Kovatchev BP, Renard E, Cobelli C et al. Feasibility of outpatient fully integrated closed-loop control first studies of wearable artificial pancreas. Diabetes Care 2013: 36: 1851-1858.
24. Place J, Robert A, Ben Brahim N et al. DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials. J Diabetes Sci Technol 2013: 7: 1427-1435.
25. Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol 2009: 3: 44-55.
26. Kovatchev B, Patek S, Dassau E et al. Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol 2009: 3: 1058-1065.
27. Hughes CS, Patek SD, Breton MD, Kovatchev BP. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data. J Diabetes Sci Technol 2010: 4: 1146-1155.
28. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979: 236: E667-E677.
29. Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ 3rd.. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol 2010: 4: 961-975.
30. Swan KL, Dziura JD, Steil GM et al. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009: 32: 240-244.
31. Tamborlane WV, Bonfig W, Boland E. Recent advances in treatment of youth with type 1 diabetes: better care through technology. Diabet Med 2001: 18: 864-870.
32. El-Khatib FH, Russell SJ, Magyar KL et al. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metabol 2014: 99: 1701-1711.
33. Chen JW, Christiansen JS, Lauritzen T. Limitations to subcutaneous insulin administration in type 1 diabetes. Diabetes Obes Metab 2003: 5: 223-233.
34. Jaser SS, Yates H, Dumser S, Whittemore R. Risky business risk behaviors in adolescents with type 1 diabetes. Diabetes Educator 2011: 37: 756-764.